Loading...
XASX
AJX
Market cap7mUSD
Jul 09, Last price  
0.01AUD
1D
-14.29%
1Q
-14.29%
Jan 2017
-98.71%
Name

Alexium International Group Ltd

Chart & Performance

D1W1MN
XASX:AJX chart
P/E
P/S
1.82
EPS
Div Yield, %
Shrs. gr., 5y
26.51%
Rev. gr., 5y
-9.00%
Revenues
4m
-33.45%
80,774,00074,711,00024,149,1014,54550,9235,01979,729298,812242,46559,1903,001,00023,894,83411,316,8305,037,0006,283,1137,285,0008,141,0007,190,0005,893,0003,921,730
Net income
-4m
L+42.21%
-47,380,000-89,636,00095,528,687-243,006-5,776,704-3,131,000-2,787,000-2,599,000-3,337,000-11,764,000-15,445,000-12,197,477-3,763,263-6,940,000-6,125,000-1,455,168-3,360,000-2,951,000-2,761,000-3,926,289
CFO
-3m
L+116.06%
-13,558,000-24,440,000-50,314,106-401,279-1,268,121-2,336,210-1,963,675-1,715,613-2,887,922-4,169,455-10,076,361-12,743,849-5,281,037-4,242,779-3,187,867-1,401,250-1,565,089-1,100,375-1,192,935-2,577,480
Dividend
Mar 24, 20050.0003 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Alexium International Group Limited is a U.S.-based firm specializing in the production and distribution of phase-change materials (PCM) and various advanced textile technologies. The company's portfolio includes a range of thermal management solutions such as Alexicool, a PCM-based chemical finish for fabrics; Biocool, which delivers natural and bio-derived PCM cooling for both textile and foam bedding; and Eclipsys, an ongoing cooling innovation designed to enhance comfort in bedding systems. Additionally, Alexium provides fire-resistant treatments like Alexiflam, engineered to impart flame retardancy to cotton, linen, other cellulosic textiles, and mattresses. Its key markets encompass the bedding, military, and workwear industries. Founded in 1994, the company's operations are headquartered in Greer, South Carolina.
IPO date
Dec 22, 1999
Employees
319
Domiciled in
AU
Incorporated in
AU

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT